The FBI’s investigation into the death of Indianapolis Colts owner Jim Irsay is raising questions about substance use and medical ethics.
Story Overview
- FBI probing Jim Irsay’s death emphasizes substance use and medical practices.
- Federal grand jury subpoena issued for records on Irsay’s treatment and death.
- Dr. Harry Haroutunian, who treated Irsay, faces scrutiny over prescriptions.
- The Colts organization and Irsay’s family grapple with uncertainty amid the investigation.
FBI Investigation into Jim Irsay’s Death
The FBI has launched a thorough investigation into the death of Indianapolis Colts owner Jim Irsay, who passed away in May 2025 at the age of 65. The inquiry centers on Irsay’s substance use and his relationship with Dr. Harry Haroutunian, a California addiction specialist.
The investigation was prompted by concerns over prescriptions of pain pills and ketamine, which have become a focal point in recent legal cases involving high-profile individuals.
Irsay’s death certificate, signed by Dr. Haroutunian, cited cardiac arrest due to pneumonia as the cause of death, with no autopsy performed. This decision not to conduct an autopsy has raised eyebrows, particularly given Irsay’s public history of addiction.
The lack of a comprehensive post-mortem examination leaves questions about the potential role of substances in his passing, echoing concerns seen in other cases like that of actor Matthew Perry.
Implications for the Colts and Irsay’s Legacy
The Indianapolis Colts, now under the ownership of Irsay’s daughters, are maintaining their operations amidst this federal probe. The organization has confirmed its awareness of the investigation but has not been directly contacted by the FBI or served with subpoenas.
This situation presents a challenge for the franchise, valued at over $4 billion, as it navigates potential reputational impacts while ensuring stability in leadership.
For Irsay’s family, the investigation adds a layer of complexity to managing his legacy and the team’s future. The probe could lead to further scrutiny of substance use in sports ownership, potentially setting a precedent for how such issues are addressed within the industry.
The investigation’s findings may also influence public perceptions of addiction treatment practices involving controlled substances like ketamine.
The FBI is investigating the death of former Colts owner Jim Irsay
The same doctor accused of supplying him with massive amounts of opioids and ketamine also signed the death certificate and ruled it a “natural” death per @washingtonpost pic.twitter.com/Eb9R8d4ekt
— Bussin' With The Boys (@BussinWTB) January 22, 2026
Ongoing Federal Inquiry and Broader Impacts
The federal investigation is still in its early stages, with the FBI and DEA actively gathering information and contacting associates of Irsay. The grand jury subpoena issued in Los Angeles seeks detailed records concerning Irsay’s death and his treatment history.
The outcome of this investigation could have far-reaching effects on the NFL and addiction treatment sectors, underscoring the importance of ethical medical practices and accountability.
Death of Indianapolis Colts owner Jim Irsay under federal investigation: Sources https://t.co/AcAsEZhKHp
— Action News on 6abc (@6abc) January 24, 2026
As the investigation unfolds, it highlights critical issues surrounding medical ethics and the responsibilities of healthcare providers in the treatment of addiction. The case underscores the need for transparency and due diligence in managing high-profile patients, ensuring that medical interventions do not compromise patient safety or legal standards.
Sources:
Colts confirm FBI investigating death of former owner Jim Irsay
Death of Colts owner Jim Irsay now a federal investigation
